Author:
Nagashima Takuya,Shirakawa Hisashi,Nakagawa Takayuki,Kaneko Shuji
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists & North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2, 596–601 (2004).
2. Sernyak, M. J. et al. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am. J. Psychiatry 159, 561–566 (2002).
3. Ely, S. F., Neitzel, A. R. & Gill, J. R. Fatal diabetic ketoacidosis and antipsychotic medication. J. Forensic Sci. 58, 398–403 (2013).
4. Buchholz, S., Morrow, A. F. & Coleman, P. L. Atypical antipsychotic-induced diabetes mellitus: an update on epidemiology and postulated mechanisms. Intern. Med. J. 38, 602–606 (2008).
5. Rojo, L. E. et al. Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology. Pharmacol. Res. 101, 74–85 (2015).
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献